Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.47 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1924678 | 0.97 | CNR2 (0.47) | CNR2MAPTMEN1KMT2ARAB9A | |
| Trimethylammonium SCHEMBL7802299 | 0.93 | CNR2 (0.49) | CNR2MAPTMEN1KMT2ARAB9A | |
| SCHEMBL12355492 | 0.87 | P2RX3 (0.48) | P2RX3ALDH1A1 | |
| SCHEMBL526383 | 0.86 | MAPT (0.58) | MAPTMEN1KMT2ARECQLLMNA | |
| Hydrochloric Acid SCHEMBL9181167 | 0.83 | MAPT (0.56) | MAPTMEN1KMT2ARECQLLMNA | |
| Ammonia Solution, Strong SCHEMBL28486254 | 0.83 | MAPT (0.56) | MAPTMEN1KMT2ARECQLLMNA | |
| Ammonia Solution, Strong SCHEMBL28483632 | 0.83 | MAPT (0.56) | MAPTMEN1KMT2ARECQLLMNA | |
| SCHEMBL15478385 | 0.81 | CNR2 (0.43) | CNR2MAPTMEN1KMT2ARAB9A | |
| SCHEMBL1801536 | 0.80 | NR1I2 (0.56) | CNR2MAPTMEN1KMT2ARAB9A | |
| SCHEMBL22874671 | 0.80 | MAOB (0.57) | MAPTMEN1KMT2ARAB9AP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 557 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| EP-4565233-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | Zydus Lifesciences Limited (IN) | 2025-06-11 | — | — | EP | claimed |
| EP-4539934-A1 | TREATMENT FOR GLOMERULAR DISEASES | Zydus Lifesciences Limited (IN) | 2025-04-23 | — | — | EP | claimed |
| CN-119816306-A | Treatment of Aplastic Anemia (AA) | 载度思生命科学有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119486735-A | For the treatment of glomerular diseases | 载度思生命科学有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119212524-A | Perovskite solar cell with chiral amine post-treatment function and preparation method thereof | 桂林电子科技大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119053210-A | Mesoscopic perovskite solar cell based on chiral perovskite heterojunction and preparation method thereof | 桂林电子科技大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118726998-A | Preparation method for preparing benzyl carboxylic acid compound from benzylamine and carbon dioxide | 哈尔滨工业大学（深圳） | 2024-10-01 | — | — | CN | claimed |
| CN-117801815-B | Chiral quasi two-dimensional perovskite film capable of emitting circularly polarized light and preparation method thereof | 天津大学 | 2024-08-09 | — | — | CN | claimed |
| US-20240173314-A1 | TREATMENT OF SICKLE CELL ANAEMIA | ZYDUS LIFESCIENCES LTD. (IN) | 2024-05-30 | — | — | US | claimed |
| EP-0910660-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINES | BAYER AG (DE) | 1999-04-28 | — | — | EP | claimed |
| EP-0906267-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1-PHENYLETHYLAMINES | BAYER AG (DE) | 1999-04-07 | — | — | EP | claimed |
| WO-1998003465-A1 | PROCESS FOR PREPARING RACEMIC PHENETHYLAMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-01-29 | — | — | WO | claimed |
| WO-1997049665-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE 1-PHENYLETHYLAMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-31 | — | — | WO | claimed |
| WO-1997046698-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-11 | — | — | WO | claimed |
| US-5144077-A | PROCESS FOR WORKING UP THE CRYSTALLIZATION MOTHER LIQUOR FROM THE RESOLUTION OF THE RACEMATE OF 1-(4-CHLOROPHENYL)-ETHYLAMINE | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-01 | — | — | US | claimed |
| EP-0208404-B1 | BENZOTHIAZINE DIOXIDE DERIVATIVES | PFIZER INC. (US) | 1990-08-29 | — | — | EP | claimed |
| EP-0208404-A2 | Benzothiazine dioxide derivatives | PFIZER INC. (US) | 1987-01-14 | — | — | EP | claimed |
| US-4634448-A | CATIONIC TRIAZINE DYES | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1987-01-06 | — | — | US | claimed |
| US-4623486-A | [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity | PFIZER INC. (US) | 1986-11-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | SSB, GRN, ALB | CNR2 3667/4885MAPT 292/4885MEN1 1156/4885 |
| US-20240173314-A1 | TREATMENT OF SICKLE CELL ANAEMIA | HBG1, HBB, HBG2 | CNR2 2094/4885MAPT 4146/4885MEN1 3116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.